Anti-Rel B antibody [EP614Y]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal Rel B antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 6 publications.
View Alternative Names
Transcription factor RelB, I-Rel, RELB
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Rel B antibody [EP614Y] (AB33907)
Immunofluorescence staining of Raji cells with purified ab33907 at a working dilution of 1/100, counter-stained with DAPI. The secondary antibody was Alexa Fluor® 488 goat anti-rabbit (ab150077), used at a dilution of 1/1000. ab7291, a mouse anti-tubulin antibody (1/1000), was used to stain tubulin along with ab150120 (Alexa Fluor® 594 goat anti-mouse, 1/1000), shown in the top right hand panel. The cells were fixed in 4 % PFA and permeabilized using 0.1% Triton X 100. The negative controls are shown in bottom middle and right hand panels - for negative control 1, purified ab33907 was used at a dilution of 1/500 followed by an Alexa Fluor® 594 goat anti-mouse antibody (ab150120) at a dilution of 1/500. For negative control 2, ab7291 (mouse anti-tubulin) was used at a dilution of 1/500 followed by an Alexa Fluor® 488 goat anti-rabbit antibody (ab150077) at a dilution of 1/400.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Rel B antibody [EP614Y] (AB33907)
Overlay histogram showing Raji cells stained with unpurified ab33907 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab33907, 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluorr® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in Raji cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Rel B antibody [EP614Y] (AB33907)
Overlay histogram showing Raji cells fixed in 80% methanol and stained with purified ab33907 at a dilution of 1/70 (red line). The secondary antibody used was Alexa Fluorr® 488 goat anti-rabbit at a dilution of 1/500. Rabbit monoclonal IgG was used as an isotype control (black line) and cells incubated in the absence of both primary and secondary antibody were used as a negative control (blue line).
- IP
Lab
Immunoprecipitation - Anti-Rel B antibody [EP614Y] (AB33907)
Rel B was immunoprecipitated from 0.35 mg of Raji (human Burkitt's lymphoma B lymphocyte), whole cell lysate with ab33907 at 1/30 dilution. Western blot was performed from the immunoprecipitate using 33907 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution. Lane 1 : Raji whole cell lysate 10 μg (Input). Lane 2 : ab33907 IP in Raji whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab33907 in Raji whole cell lysate. Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 180 seconds.
All lanes:
Immunoprecipitation - Anti-Rel B antibody [EP614Y] (ab33907) at 1/1000 dilution
Lane 1:
Raji whole cell lysate at 10 µg
Lane 2:
ab33907 IP in Raji whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 62 kDa
Observed band size: 62 kDa
false
Exposure time: 180s
- IP
Unknown
Immunoprecipitation - Anti-Rel B antibody [EP614Y] (AB33907)
ab33907 (purified) at 1/20 immunoprecipitating Rel B in 10 μg Daudi cell lysate (Lanes 1 and 2, observed at 70 kDa). Lane 3 - Rabbit monoclonal IgG (ab172730). For western blotting, HRP Veriblot for IP (ab131366) was used for detection (1/1000). Blocking buffer and concentration : 5% NFDM/TBST Dilution buffer and concentration : 5% NFDM/TBST
All lanes:
Immunoprecipitation - Anti-Rel B antibody [EP614Y] (ab33907)
Predicted band size: 62 kDa
false
- WB
Unknown
Western blot - Anti-Rel B antibody [EP614Y] (AB33907)
All lanes:
Western blot - Anti-Rel B antibody [EP614Y] (ab33907) at 1/20000 dilution
All lanes:
Raji Cell Lysate
Predicted band size: 62 kDa
Observed band size: 62 kDa
false
- WB
Lab
Western blot - Anti-Rel B antibody [EP614Y] (AB33907)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Rel B antibody [EP614Y] (ab33907) at 1/2000 dilution
Lane 1:
Raji cell lysate at 20 µg
Lane 2:
Daudi cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 62 kDa
Observed band size: 70 kDa
false
- WB
Lab
Western blot - Anti-Rel B antibody [EP614Y] (AB33907)
Lanes 1- 4 : Merged signal (red and green). Green - ab33907 observed at 70 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab33907 was shown to react with Rel B in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265948 (knockout cell lysate ab257635) was used. Wild-type HeLa and RELB knockout HeLa cell lysates were subjected to SDS-PAGE. ab33907 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Rel B antibody [EP614Y] (ab33907) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 40 µg
Lane 2:
RELB knockout HeLa cell lysate at 40 µg
Lane 2:
Western blot - Human RELB (Rel B) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-relb-rel-b-knockout-hela-cell-line-ab265948'>ab265948</a>)
Lane 3:
Raji cell lysate at 40 µg
Lane 4:
LnCap cell lysate at 40 µg
Predicted band size: 62 kDa
Observed band size: 70 kDa
false
Related conjugates and formulations (3)
-
578 PE
PE Anti-Rel B antibody [EP614Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Rel B antibody [EP614Y]
-
Anti-Rel B antibody [EP614Y] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Rel B serves as a critical component of the alternative NF-κB signaling pathway. It often forms a complex with another NF-κB family member called p52. This complex controls the transcription of genes involved in the immune response cell survival and differentiation. Additionally Rel B contributes to the development of secondary lymphoid organs and modulation of immune responses.
Pathways
Rel B integrates into the non-canonical NF-κB signaling pathway also influencing the canonical pathway to a lesser extent. In the non-canonical pathway Rel B interacts with NIK and p100 to influence immune cell function. This involvement makes Rel B essential in processes like adaptive immunity and inflammatory responses. The protein p52 closely associates with Rel B aiding its activity in these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Signal transduction and targeted therapy 10:43 PubMed39865075
2025
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:1624 PubMed34926668
2021
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 22:e52032 PubMed34105235
2021
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 14:1553-1564 PubMed33688203
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 120:3978-3988 PubMed30378143
2018
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 284:27857-65 PubMed19690169
2009
Applications
IP
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com